Company Delays Product Launch to Avoid Payouts to Securities Holders

ByJoseph O'Neill

|

Updated onJanuary 6, 2018

Company Delays Product Launch to Avoid Payouts to Securities Holders

This case involves a defendant medical device company that allegedly breached its contract with securities holders. The company intentionally delayed the process of FDA approval and did not sufficiently market a new surgical device in order to avoid performance based payouts to securities holders. As a result of doing so, the medical device company is thought to have made several hundred million dollars. It was claimed that the company’s behavior in this incident represented a significant departure from the industry norms involved in marketing a novel medical device, in that they did not aggressively pursue FDA approval or market the device despite forecasts of the device’s probable success in the market.

Question(s) For Expert Witness

1. Please briefly describe your work marketing medical devices

2. Could you review the facts of the case to determine whether or not the defendants marketing efforts were sufficient?

Expert Witness Response E-075178

inline imageI have held leadership positions within most all functions of commercial operations of pharmaceutical and biotechnology firms. I have led brand teams to launch products as a marketing director, owned product, portfolio, and enterprise profit and loss statements as the head of primary care and specialty marketing business unit, managed the brand planning and budgeting process, led strategic global business unit level planning sessions, and overseen commercial operations. Currently, I run a consultancy that advises on organizational design, as well as corporate and brand strategic planning for the launch of new assets. I have also worked on in-licensing and out-licensing deals, co-promotions, and joint ventures. I can opine on the process of launching products in this space, and can determine realistic parameters for promotional spending as a percent of expected net sales. I also can speak to what it takes to be successful in the surgical device marketplace. I also have the capability to conduct competitive intelligence into the marketplace and give an assessment of this marketing plan compared to that of the competition. I have reviewed, critiqued, adjusted and relaunched marketing plans for other products, and I would be applying those skills to this particular case. There are usually huge marketing efforts undertaken for surgical devices, and I think I could determine fairly quickly if the defendant's efforts were insufficient.

About the author

Joseph O'Neill

Joseph O'Neill

Joe has extensive experience in online journalism and technical writing across a range of legal topics, including personal injury, meidcal malpractice, mass torts, consumer litigation, commercial litigation, and more. Joe spent close to six years working at Expert Institute, finishing up his role here as Director of Marketing. He has considerable knowledge across an array of legal topics pertaining to expert witnesses. Currently, Joe servces as Owner and Demand Generation Consultant at LightSail Consulting.

Find an expert witness near you

What State is your case in?

What party are you representing?

background image

Subscribe to our newsletter

Join our newsletter to stay up to date on legal news, insights and product updates from Expert Institute.